Intravitreal Dexamethasone Implant in Autoimmune Retinopathy
- PMID: 37035523
- PMCID: PMC10081906
- DOI: 10.1155/2023/5670538
Intravitreal Dexamethasone Implant in Autoimmune Retinopathy
Abstract
Purpose: To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR).
Methods: Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography, visual fields, and electroretinography.
Results: The patients showed an interruption of the functional losses and remained stable with semestral injections.
Conclusion: AIR is a complex condition with no standard treatment. The use of dexamethasone could be a valid option.
Copyright © 2023 Fernando Longhi Bordin et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
